Teva Pharmaceutical Industries Ltd Stock Ownership - Who owns Teva Pharmaceutical Industries?

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?
Sven DethlefsEVP North America Commercial2023-03-0758,066$9.43
Richard DaniellExec. VP European Commercial2023-03-0754,007$9.43
Eric DrapeExecutive VP Global Operations2023-03-074,699$9.43
David Matthew StarkExec. VP Chief Legal Officer2023-03-0749,475$9.43
Richard DaniellExec. VP European Commercial2023-03-0618,002$9.93
David Matthew StarkExec. VP Chief Legal Officer2023-03-0616,491$9.93
Eric DrapeExecutive VP Global Operations2023-03-061,566$9.93
Sven DethlefsEVP North America Commercial2023-03-0619,355$9.93
Eric DrapeExecutive VP Global Operations2023-02-289,797$9.89
Richard DaniellExec. VP European Commercial2023-02-2820,598$9.89

1 of 2

TEVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TEVA insiders and whales buy or sell their stock.

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?
Capital Research Global Investors7.38%82,644,367$597.52MInstitution
Capital World Investors4.52%50,639,163$366.12MInstitution
Blackrock Inc3.58%40,166,381$290.40MInstitution
Ion Asset Management Ltd2.52%28,190,724$203.82MInstitution
Menora Mivtachim Holdings Ltd2.38%26,641,218$192.62MInstitution
Migdal Insurance Financial Holdings Ltd2.08%23,346,560$168.80MInstitution
Harel Insurance Investments Financial Services Ltd2.08%23,298,179$168.45MInstitution
Phoenix Holdings Ltd1.98%22,133,802$160.03MInstitution
State Street Corp1.75%19,564,828$141.45MInstitution
Clal Insurance Enterprises Holdings Ltd1.68%18,835,666$136.18MInstitution

1 of 3

TEVA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TEVA49.69%0.79%Net SellingNet Selling
CTLT78.69%21.31%Net SellingNet Selling
VTRS75.14%17.68%Net Selling
ELAN90.55%9.45%Net SellingNet Buying

Teva Pharmaceutical Industries Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE: TEVA) is owned by 49.69% institutional shareholders, 0.79% Teva Pharmaceutical Industries insiders, and 49.52% retail investors. Capital Research Global Investors is the largest individual Teva Pharmaceutical Industries shareholder, owning 82.64M shares representing 7.38% of the company. Capital Research Global Investors's Teva Pharmaceutical Industries shares are currently valued at $595.87M.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.